Expertise in
6
conditions

Dr. Michael P. Hopkins

Gynecologic Oncology | Oncology
224 W Exchange St, Suite 140, 
Akron, OH 
Accepting New Patients
Expertise in
6
conditions
224 W Exchange St, Suite 140, 
Akron, OH 

Overview

Michael Hopkins is a Gynecologic Oncologist and an Oncologist practicing medicine in Akron, Ohio.

Dr. Hopkins is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Hysterectomy.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 4 clinical trials. Dr. Hopkins is currently accepting new patients.

Specialties

Gynecologic Oncology
Oncology

Licenses

Obstetrics & Gynecology in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Medical Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

224 W Exchange St, Suite 140, Akron, OH 44302

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Radiation, Drug, Other
Study Drugs: Cisplatin, Triapine
Study Phase: Phase 3
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
View 3 Less Clinical Trials

8 Total Publications

Time to Next Available Appointment as an Access to Care Metric.
Time to Next Available Appointment as an Access to Care Metric.
Journal: Joint Commission journal on quality and patient safety
Published: July 04, 2019
Similar Doctors
Expertise in
27
conditions
Dr. David Peereboom
Oncology | Hematology Oncology
Expertise in
27
conditions
Dr. David Peereboom
Oncology | Hematology Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (29.5 miles away)
866-223-8100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Peereboom is an Oncologist and a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. Dr. Peereboom is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Glioma, Astrocytoma, and Bone Marrow Aspiration. Dr. Peereboom is board certified in United Council For Neurological Subspecialties, 2008.

Expertise in
18
conditions
Dr. Afshin Dowlati
Oncology
Expertise in
18
conditions
Dr. Afshin Dowlati
Oncology

University Hospitals

11100 Euclid Ave, 
Cleveland, OH 
 (29.8 miles away)
216-844-1228
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Afshin Dowlati is an Oncologist practicing medicine in Cleveland, Ohio. Dr. Dowlati is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Bone Marrow Aspiration.

Expertise in
21
conditions
Dr. Alok Khorana
Oncology
Expertise in
21
conditions
Dr. Alok Khorana
Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (29.5 miles away)
866-223-8100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alok Khorana is an Oncologist practicing medicine in Cleveland, Ohio. Dr. Khorana is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Pancreatic Cancer, Colorectal Cancer, Pancreatectomy, and Endoscopy. Dr. Khorana is board certified in American Board Of Internal Medicine, 2002.

Frequently Asked Questions about Dr. Michael P. Hopkins

How do I make an appointment with Dr. Michael P. Hopkins?

You can book an appointment with Dr. Michael P. Hopkins by calling their office at 330-344-6041. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael P. Hopkins a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael P. Hopkins is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael P. Hopkins specialize in?

While Dr. Michael P. Hopkins is a Gynecologic Oncology, they have specific expertise in Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Malignant Mixed Mullerian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gynecologic Oncology.

Does Dr. Michael P. Hopkins participate in research or clinical trials?

Yes. Dr. Michael P. Hopkins has published 8 articles and abstracts on conditions like Cervical Cancer. You can view a list of Dr. Michael P. Hopkins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael P. Hopkins accept my insurance?

Dr. Michael P. Hopkins accepts most major insurance plans, including Anthem BCBS and CareSource. We recommend calling the office directly at 330-344-6041 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hopkins's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile